NANOG and liver cancer: The high early mortality and metastasis rate of liver cancer is due to the spread of tumor cells from the original place into the blood We take the content of Nanog+ CSCs in the blood and tissues of cancer patients as a new target for evaluating the survival and recurrence of cancer patients.